Many patients taking GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) experience digestive side effects including nausea, bloating, and altered bowel habits
This dual signaling often results in superior appetite control and, in many large clinical trials, a higher total percentage of body weight loss compared to Semaglutide
Consult a Medical Professional Always undergo a proper consultation
A., De Mari M., Marconi R., Filla A., Bonnet A.-M., Broussolle E., Pollak P., Rascol O., Rosier M., Arnould A., Association between early-onset Parkinsons disease and mutations in the parkin gene
Theyre managing stress
I just have a negative association with eating, he tells WIRED